KeyBanc Lowers Price Target on Tempur-Pedic (TPX), Strong Long-Term Buy
Tweet
Share
E-mailGet Alerts TPX Hot Sheet
Price: $68.78 --0%
Rating Summary:
12 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
12 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
KeyBanc is reaffirming its Buy rating on shares of Tempur-Pedic (NYSE: TPX), but is lowering its price target from $80 to $73.
The firm reports that retails continue to be positive with the performance of Tempur-Pedic. Market checks indicate that many retailers are offering promotions such as zero percent financing and free pillows. KeyBanc views this as a positive and as accesorries and continue to outpace mattress in the domestic sector.
KeyBanc is reiterating its third quarter earnings estimate of $0.86 as domestic sales remain on track to grow over 20 percent in the quarter.
An analyst at the firm comments, "Longer term, we continue to view TPX as one of the more compelling growth stories as it refines its product assortment and grows domestic and international awareness. The stock has declined by 22% since its July 29 high, vs. a 10% decline for the S&P 500, which we believe supports an attractive entry point for this quality growth story."
For 2011 and 2012, KeyBanc estimates earnings of $3.13 and $3.75.
For more ratings news on Tempur-Pedic click here and for the rating history of Tempur-Pedic click here.
Shares of Tempur-Pedic closed at $56.32 yesterday.
The firm reports that retails continue to be positive with the performance of Tempur-Pedic. Market checks indicate that many retailers are offering promotions such as zero percent financing and free pillows. KeyBanc views this as a positive and as accesorries and continue to outpace mattress in the domestic sector.
KeyBanc is reiterating its third quarter earnings estimate of $0.86 as domestic sales remain on track to grow over 20 percent in the quarter.
An analyst at the firm comments, "Longer term, we continue to view TPX as one of the more compelling growth stories as it refines its product assortment and grows domestic and international awareness. The stock has declined by 22% since its July 29 high, vs. a 10% decline for the S&P 500, which we believe supports an attractive entry point for this quality growth story."
For 2011 and 2012, KeyBanc estimates earnings of $3.13 and $3.75.
For more ratings news on Tempur-Pedic click here and for the rating history of Tempur-Pedic click here.
Shares of Tempur-Pedic closed at $56.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Investing.com’s stocks of the week
- Jefferies Downgrades Klepierre SA (LI:FP) (KLPEF) to Hold
- Jefferies Upgrades ITC Ltd. (ITC:IN) to Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
KeyBanc, Standard & Poor's, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
